ID   NCC-SS3-C1
AC   CVCL_ZC97
DR   Wikidata; Q98127435
RX   PubMed=32274656;
WW   Provider; BizCom; -; https://en.cellline.jp/product/ncc-ss3-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 60 hours (PubMed=32274656).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=32274656).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=32274656
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D21S11: 31,31.2
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
RX   PubMed=32274656; DOI=10.1007/s13577-020-00354-6;
RA   Yoshimatsu Y., Noguchi R., Tsuchiya R., Sei A., Sugaya J., Iwata S.,
RA   Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-SS3-C1: a novel
RT   patient-derived cell line of synovial sarcoma.";
RL   Hum. Cell 33:877-885(2020).
//